EICHORCondition: Alpha 1-Antitrypsin Deficiency · Emphysema · Sponsor: Sanofi
Phase 2 study to compare SAR447537 (INBRX-101) to plasma derived A1PI therapy in adults with AATD emphysema
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham- Site Number : 105 | Birmingham, Alabama, United States | — |
| University of Alabama at Birmingham | Birmingham, Alabama, United States | — |
| St Joseph's Hospital and Medical Center- Site Number : 126 | Phoenix, Arizona, United States | — |
| St Joseph's Hospital and Medical Center | Phoenix, Arizona, United States | — |
| David Geffen School of Medicine- Site Number : 124 | Los Angeles, California, United States | — |
| David Geffen School of Medicine | Los Angeles, California, United States | — |
| UC Davis Comprehensive Cancer Center- Site Number : 110 | Sacramento, California, United States | — |
| UC Davis Medical Center | Sacramento, California, United States | — |
| National Jewish Medical and Research Center- Site Number : 123 | Denver, Colorado, United States | — |
| National Jewish Medical and Research Center | Denver, Colorado, United States | — |
| Western Connecticut Medical Group | Danbury, Connecticut, United States | — |
| University of Florida College of Medicine- Site Number : 101 | Gainesville, Florida, United States | — |
+ 53 more locations — full list on the registry record.
Sponsor or site team? See the site landscape for this trial — listed sites, countries, and recruiting-density context.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05856331